-
-
-
-
-
-
-
Biogen (BIIB) PT Raised to $200 at BofA Securities
-
-
-
-
-
-
-
Biogen shares rise as Q4 earnings beat expectations, 2026 profit outlook strong
-
-
-
-
-
-
-
Where can biotech stocks go from here? RBC answers
-
-
-
-
-
-
-
Jefferies sees 'an attractive setup' in this large biotech stock
-
-
-
-
-
-
-
Goldman Sachs Reiterates Buy Rating on Biogen (BIIB)
-
-
-
-
-
-
-
Biogen (BIIB) Biogen Q4 earnings preview: here’s what to expect
-
-
-
-
-
-
-
Biogen (BIIB) Tops Q3 EPS by 31c; raises guidance
-
1,198,739 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

